@PulmAdvisor

Pulmonology Advisor is a comprehensive resource for healthcare professionals focused on pulmonary and critical care medicine.

 New York, NY
pulmonologyadvisor.com/
Joined March 2017
  • Tweets6.4K
  • Following68
  • Followers1.8K
2.6KMedia
🚨 Heading to #CHEST2026 with @accpchest this weekend? Follow along with Pulmonology Advisor as we cover all the latest research presenting at the conference. #PulmTwitter 🫁 pulmonologyadvisor.com/repor…

Get Set to Navigate the Horizon of Pulmonary Care at CHEST 2026

The CHEST 2026 Annual Meeting will take place October 18 to 21 in Phoenix, Arizona and will feature more than 300 educational sessions.

pulmonologyadvisor.com
1
3
235
From @journal_CHEST 🫁 Parameters related to the #PulmonaryArtery stiffness-right ventricular interplay may be significant predictors of mortality in patients with #PulmonaryHypertension. #PulmTwitter pulmonologyadvisor.com/news/…

Pulmonary Artery Stiffness-RV Interplay Predicts Mortality in Pulmonary Hypertension

In patients with pulmonary hypertension, measures of pulmonary artery stiffness and RV function may be significant predictors of mortality.

pulmonologyadvisor.com
2
3
147
From @NEJM 🫁 Catheter-directed #thrombolysis plus #anticoagulation was associated with reduced risk of mortality among patients with acute #PulmonaryEmbolism. #PulmTwitter #CriticalCare pulmonologyadvisor.com/news/…

Catheter-Directed Thrombolysis Plus Anticoagulation Supported in Acute PE

Among patients with acute PE, those who undergo catheter-directed thrombolysis plus anticoagulation therapy show better outcomes.

pulmonologyadvisor.com
76
From @journal_CHEST 🫁🚨 The American College of Chest Physicians (@accpchest) has released a clinical practice guideline on #TobaccoTreatment in the inpatient setting. #PulmTwitter pulmonologyadvisor.com/featu…

CHEST Releases Guideline on Tobacco Treatment in Inpatient Setting

The American College of Chest Physicians (CHEST) has released a clinical practice guideline on tobacco treatment in the inpatient setting.

pulmonologyadvisor.com
3
6
252
From @ATSBlueEditor 🦠🫁 The @NYCHA #MoldBusters intervention was associated with significantly reduced #asthma-related #EmergencyDepartment visit rates for #PublicHousing residents. #PulmTwitter #PublicHealth pulmonologyadvisor.com/news/…

Mold Intervention in Public Housing Reduces Asthma ED Visits

A mold intervention program introduced in NYC public housing developments was associated with reduced ED visits for residents with asthma.

pulmonologyadvisor.com
1
64
Strict diagnostic yield was significantly higher for patients with peripheral #PulmonaryLesions who underwent robotic vs nonrobotic #bronchoscopy, indicating the utility of advanced bronchoscopy techniques. #PulmTwitter pulmonologyadvisor.com/news/…

Higher Diagnostic Yield and Accuracy in Robotic Bronchoscopy

Compared with a nonrobotic platform, robotic bronchoscopy was associated with increased diagnostic yield and accuracy for pulmonary lesions.

pulmonologyadvisor.com
1
1
64
From @journal_CHEST 🫁 Although incidental #emphysema detected via routine chest CT correlates with higher all-cause and #LungCancer-specific mortality risk, it does not independently stratify patient prognosis beyond known smoking history. #PulmTwitter pulmonologyadvisor.com/news/…

Emphysema on Routine Chest CT Linked to Mortality in Current, Former Smokers 

Emphysema among individuals with a history of smoking via routine chest CT is associated with increased risk of all-cause mortality risk.

pulmonologyadvisor.com
62
From @JAMANetworkOpen 🫁 Continuation of #InhaledCorticosteroids for #asthma during the first trimester of #pregnancy was not significantly associated with increased risk for adverse maternal or neonatal outcomes. #PulmTwitter #OBGYNTwitter pulmonologyadvisor.com/news/…

Continued ICS Use for Asthma in Early Pregnancy Not Linked to Adverse Outcomes 

For pregnant women with asthma during their first trimester, continued ICS use was not associated with increased risk for adverse outcomes.

pulmonologyadvisor.com
69
From @AnnalsAllergy: Lower likelihood of #FoodAllergy resolution was associated with multiple factors, including lower income, limited health literacy, and #RacialDisparities. pulmonologyadvisor.com/news/…

Socioeconomic Disparities Reduce Likelihood of Food Allergy Resolution in Children

Racial/ethnic disparities and worse socioeconomic conditions are associated with a reduced likelihood of FA resolution in children.

pulmonologyadvisor.com
2
2
101
From @JAMANetworkOpen 🫁🦠 Elevated levels of the chemokine CCL5 may be an effective prognostic biomarker in respiratory #ViralInfections, showing protective associations against mortality and unfavorable disease progression. pulmonologyadvisor.com/news/…

Elevated CCL5 Linked to Favorable Outcomes in Respiratory Viral Infections

Patients with respiratory viral infections and high CCL5 levels demonstrate improved survival and reduced risk for severe disease progression.

pulmonologyadvisor.com
1
1
74
The NEWS2 scoring system provides a more comprehensive framework than shock-based assessment alone for identifying #antibiotic urgency in patients with suspected #sepsis at risk for severe outcomes. @BrighamWomens @MassGeneralNews @TAMUmedicine pulmonologyadvisor.com/news/…

Antibiotic Urgency in Suspected Sepsis Effectively Identified With NEWS2 Scores

High-risk NEWS2 scores effectively identify patients with suspected sepsis who require urgent antibiotics to prevent in-hospital mortality.

pulmonologyadvisor.com
61
🫁 Expiratory CT measures had the strongest discrimination for identifying chronic airway limitation, indicating their utility over inspiratory CT measures. #DiagnosticImaging #PulmTwitter pulmonologyadvisor.com/news/…

Expiratory CT Outperforms Inspiratory CT in Identifying Chronic Airflow Limitation

Quantitative expiratory CT measures outperformed inspiratory CT measures in identifying chronic airflow limitation, an indication of COPD.

pulmonologyadvisor.com
48
From @journal_CHEST 🫁 A single moderate exacerbation in patients with #COPD was associated with increased risk for future severe exacerbations and all-cause mortality, supporting the use of updated GOLD 2026 criteria. #PulmTwitter pulmonologyadvisor.com/news/…

Mortality Risk in Patients With COPD Higher After 1 Moderate Exacerbation

Patients with COPD who experience at least 1 moderate exacerbation may be at increased risk of all-cause mortality.

pulmonologyadvisor.com
2
3
151
In patients with #NonSmallCellLungCancer, active imaging surveillance may improve overall survival following definitive treatment. #PulmTwitter #OncTwitter pulmonologyadvisor.com/news/…

Active Surveillance Shows Survival Benefit in Non-Small Cell Lung Cancer

Active post-treatment imaging surveillance was significantly associated with decreased mortality risk among patients with NSCLC.

pulmonologyadvisor.com
1
1
68
From @journal_CHEST 🫁 Female-only models outperformed combined-sex and male-only models in predicting both #COPD incidence and prevalence, which could improve early identification of disease. #HealthDisparities #PulmTwitter pulmonologyadvisor.com/news/…

Sex-Specific Models May Improve COPD Risk Prediction

Researchers developed sex-specific models using CT imaging and compared their efficacy in predicting the incidence and prevalence of COPD.

pulmonologyadvisor.com
2
3
167
From @AnnalsAllergy 🫁 Improvements in peripheral airway reactance via #BiologicTherapy were significantly associated with clinical remission in patients with severe #asthma. #PulmTwitter pulmonologyadvisor.com/news/…

Clinical Remission in Asthma Linked to Improvements in Peripheral Airway Reactance

Patients with asthma who had improved peripheral airway reactance following biologics showed increased likelihood of clinical remission.

pulmonologyadvisor.com
2
2
114
From @accpchest 🫁 #Dupilumab was not associated with a significantly increased risk for #lymphoma when compared with other biologics in patients with severe #asthma, though further studies with longer follow-up periods are warranted. #PulmTwitter pulmonologyadvisor.com/news/…

Lymphoma Risk in Severe Asthma Similar Between Dupilumab vs Other Biologics

Compared with other biologic therapies, dupilumab did not significantly increase risk for lymphoma among adults with severe asthma.

pulmonologyadvisor.com
1
3
68
From @accpchest 🫁 Patients with #COPD and #T2DM showed lower lung cancer risk with #SGLT2Inhibitor initiation than with #sulfonylureas medications, particularly men and those with a history of smoking. pulmonologyadvisor.com/news/…

Lung Cancer Risk Lower With SGLT2 Inhibitors vs Sulfonylureas in COPD Plus T2DM

Researchers conducted a cohort study to compare lung cancer risk among patients with COPD and T2DM using SGLT2 inhibitors vs sulfonylureas.

pulmonologyadvisor.com
1
3
72
#Pulmonologists involved in familial #InterstitialLungDisease care reported significant geographic and institutional differences in access to genetic testing and multidisciplinary teams. #HealthDisparities #PulmTwitter pulmonologyadvisor.com/news/…

Survey of Pulmonologists Shows Significant Differences in Familial ILD Management 

Global access to genetic screening and multidisciplinary teams for familial ILD varies significantly by region and institution.

pulmonologyadvisor.com
2
1
70
From @jacionline ℹ️ Although superiority was not established between the use of dupilumab, tezepelumab, and stapokibart in severe #ChronicRhinosinusitis with nasal polyps, all 3 demonstrated greater clinical benefits vs other #biologics. pulmonologyadvisor.com/news/…

Chronic Rhinosinusitis With Nasal Polyps: Biologics With Greatest Clinical Benefit

Dupilumab, tezepelumab, and stapokibart may offer greater clinical benefits than other biologics for patients with severe CRSwNP.

pulmonologyadvisor.com
1
3
127
Load more